Results 241 to 250 of about 13,563,242 (300)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Network-based performance analysis of multidimensional performance characteristics in trained male youth combat athletes. [PDF]

open access: yesFront Sports Act Living
Kernluea S   +7 more
europepmc   +1 more source

RhoA/ROCK signaling as a potential convergent pathway in microbiota-gut-brain axis-related cognitive impairment. [PDF]

open access: yesFront Neurol
Cao Y   +11 more
europepmc   +1 more source

Koresponden Influence Journal [PDF]

open access: yes
Widijowati, Rr Dijan
core  

Home - About - Disclaimer - Privacy